Bank Of America Corp Kal Vista Pharmaceuticals, Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 110,050 shares of KALV stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,050
Previous 52,694
108.85%
Holding current value
$1.07 Million
Previous $610,000
52.79%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding KALV
# of Institutions
130Shares Held
52.1MCall Options Held
63.5KPut Options Held
36.6K-
Vr Adviser, LLC New York, NY6.25MShares$61 Million8.73% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$48 Million1.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$47.8 Million3.11% of portfolio
-
Vestal Point Capital, LP New York, NY4.77MShares$46.6 Million2.4% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.69MShares$36 Million2.3% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $240M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...